By Dan Catizone, QuickSTAT
Much has been written about cold chain logistics, however, successful and efficient planning still presents many challenges. One of them is choosing an appropriate packaging system. (You can learn more about overcoming cold chain logistics challenges in our white paper, "Best Practices in Cold Chain Logistics Planning".)
Marken is hosting their Chicago installation of the "Quality of Supply Chain Quality Agreements" workshop series on Tuesday, October 1, 2013, in conjunction with IQPC's 11th Annual Cold Chain and Temperature Control Global Forum.
By Paul Held, Laboratory Manager, Applications Department, BioTek Instruments, Inc.
The production of ethanol for use as a biofuel from grains or cellulosic material requires the hydrolysis of carbohydrate polymers such as cellulose, xylan, and starch to monomeric sugars that are fermentable by cellular organisms such as bacteria and yeast.
ReadyToProcess™ columns are prepacked, prequalified, and presanitized process chromatography columns suited for purification of biopharmaceuticals (e.g. proteins, vaccines, plasmids, and viruses) for clinical phase 1 and 2 studies. ReadyToProcess columns are available with several media at different volumes (1, 2.5, 10, and 20 liters).
By Martha Folmsbee, Morven McAlister, and Jerold Martin, Pall Life Sciences
Martha Folmsbee, Morven McAlister, and Jerold Martin, at Pall Life Sciences, discuss some of the challenges involved in the validation of sterilizing filters for mycoplasma removal, and the importance of the associated process-specific tests, compared to the filter manufacturer's standard tests.
By Thomas O’Brien, Ph.D., 3M Purification
Activated carbon in the pharmaceutical industry has been used for many years to reduce impurities derived from the reactions that create active pharmaceutical ingredients (APIs). The adsorptive properties and very large surface area of activated carbon make it ideal for filtering impurities from APIs, with decolorization being the most common pharmaceutical application.
By Ken Peterson, MasterControl
The medical device industry faces the challenge of delivering safe and cost-effective products on time, every time. The pressure to put products into the marketplace is undoubtedly intensified by the strict guidelines enforced by the FDA and other regulatory bodies worldwide. Medical device companies are under obligation to meet market demands, while complying fully with regulatory requirements.
October 28 to 30, 2013 • The Ritz-Carlton, Laguna Niguel, CA
Since 2003, BioNetwork has been providing the essential platform for business development executives across the pharmaceutical and biotechnology space to efficiently come together in an intimate setting and develop relationships that lead to strategic partnerships. Learn more.
Pharma/Biotechs — Get 25 percent off with code BN13LSL.